Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
Status:
Unknown status
Trial end date:
2019-06-23
Target enrollment:
Participant gender:
Summary
We conduct the clinical trial to further explore the efficacy and safety of Apatinib combined
with chemotherapy in treating recurrent or metastatic esophageal squamous cell carcinoma
after the failure of conventional treatments.
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital of Anhui Medical University